Acadian Asset Management
BOLD

Acadian Asset Management’s Boundless Bio BOLD Stock Holding History

Acadian Asset Management’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12K Hold
12,610
– – ﹤0.01% 1973
2025
Q4 		$14K Sell
12,610
-1,143
-8% -$1.42K ﹤0.01% 1920
2025
Q3 		$16K Hold
13,753
– – ﹤0.01% 1784
2025
Q2 		$13K Sell
13,753
-8,334
-38% -$11.1K ﹤0.01% 1603
2025
Q1 		$31K Hold
22,087
– – ﹤0.01% 1493
2024
Q4 		$63K Buy
+22,087
New +$64.4K ﹤0.01% 1429

Other funds holding BOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Acadian Asset Management's BOLD Position: Q1 2026 in Review

Acadian Asset Management held its Boundless Bio (BOLD) position steady in Q1 2026 at 12,610 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #1973.

Acadian Asset Management first reported a position in BOLD in Q4 2024 and has held it in 6 quarters since. The position peaked at $63K in Q4 2024. 36 funds tracked by Wall St. Rank hold BOLD as of Q1 2026.

  • Acadian Asset Management held 12,610 shares of Boundless Bio worth $12K as of Q1 2026.
  • Acadian Asset Management left its Boundless Bio share count unchanged in Q1 2026.
  • Boundless Bio made up ﹤0.01% of Acadian Asset Management's portfolio in Q1 2026, its #1973 holding.
  • Acadian Asset Management first reported a position in Boundless Bio in Q4 2024 and has held it in 6 quarters since.
  • Acadian Asset Management's Boundless Bio position peaked at $63K in Q4 2024.
  • 36 funds tracked by Wall St. Rank held Boundless Bio as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.